The 3′ untranslated region of the lipoprotein lipase gene:: Haplotype structure and association with post-heparin plasma lipase activity

被引:29
作者
Goodarzi, MO
Wong, H
Quiñones, MJ
Taylor, KD
Guo, XQ
Castellani, LW
Antoine, HJ
Yang, HY
Hsueh, WA
Rotter, JI
机构
[1] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Dept Med, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA
[3] Univ Calif Los Angeles, Lipid Res Lab, Vet Affairs Greater Los Angeles Healthcare Ctr, Los Angeles, CA 90073 USA
[4] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90073 USA
[5] Univ Calif Los Angeles, Div Endocrinol, Los Angeles, CA 90025 USA
[6] Univ Calif Los Angeles, Div Diabet & Hypertens, Los Angeles, CA 90025 USA
[7] Univ Calif Los Angeles, Div Cardiol, Dept Med, David Geffen Sch Med, Los Angeles, CA 90025 USA
关键词
D O I
10.1210/jc.2005-0389
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Haplotypes comprising six single nucleotide polymorphisms (SNPs) (intron 7 to intron 9) of the lipoprotein lipase (LPL) gene appear to influence risk for atherosclerosis and insulin resistance in Mexican-Americans. Objective: Based on rodent studies, we hypothesized that these haplotypes are in linkage disequilibrium with functional variants in the 3' untranslated region of LPL, which is encoded by exon 10, and that these variants influence phenotype by altering LPL expression. Design: We sequenced exon 10 in subjects with divergent insulin sensitivity and divergent haplotypes. We also sequenced the other common LPL haplotypes. Variants identified by sequencing were genotyped in a large, family-based population along with the six SNPs spanning intron 7 to intron 9. We tested the potential functional significance of variation in exon 10 by evaluating association of haplotypes with post-heparin plasma LPL activity. Setting: The study took place within the general community, with the Mexican-American Coronary Artery Disease Project cohort. Participants: Participants included 847 subjects from 163 families. Main Outcome Measures: We determined LPL haplogenotype and post-heparin plasma LPL activity. Results: Exon 10 sequencing identified 15 variants. Thirteen of these variants were genotyped in large-scale along with the six SNPs spanning intron 7 to intron 9. LPL haplotypes and their relative frequencies in Mexican-Americans were determined. The fourth most common haplotype based on 19 SNPs (haplotype 19-4) was associated with increased LPL activity as well as multiple phenotypes related to the metabolic syndrome. Conclusions: These results support the possibility that variation in the 3' untranslated region of LPL affects LPL expression and activity, consequently influencing risk of atherosclerosis and insulin resistance, and provides important tools for further dissection of LPL regulation.
引用
收藏
页码:4816 / 4823
页数:8
相关论文
共 40 条
[1]   ASSOCIATION OF LIPOPROTEIN-LIPASE GENE VARIATION WITH THE PHYSIOLOGICAL COMPONENTS OF THE INSULIN-RESISTANCE SYNDROME IN THE POPULATION OF THE SAN-LUIS-VALLEY, COLORADO [J].
AHN, YI ;
FERRELL, RE ;
HAMMAN, RF ;
KAMBOH, MI .
DIABETES CARE, 1993, 16 (11) :1502-1506
[2]   Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p [J].
Allayee, H ;
de Bruin, TWA ;
Dominguez, KM ;
Cheng, LSC ;
Ipp, E ;
Cantor, RM ;
Krass, KL ;
Keulen, ETP ;
Aouizerat, BE ;
Lusis, AJ ;
Rotter, JI .
HYPERTENSION, 2001, 38 (04) :773-778
[3]   Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[4]   Mechanisms mediating insulin resistance in transgenic mice overexpressing mouse apolipoprotein A-II [J].
Castellani, LW ;
Gargalovic, P ;
Febbraio, M ;
Charugundla, S ;
Jien, ML ;
Lusis, AJ .
JOURNAL OF LIPID RESEARCH, 2004, 45 (12) :2377-2387
[5]   Overexpression of apolipoprotein all in transgenic mice converts high density lipoproteins to proinflammatory particles [J].
Castellani, LW ;
Navab, M ;
VanLenten, BJ ;
Hedrick, CC ;
Hama, SY ;
Goto, AM ;
Fogelman, AM ;
Lusis, AJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (02) :464-474
[6]  
DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
[7]   ANALYSIS OF DNA CHANGES IN THE LPL GENE IN PATIENTS WITH FAMILIAL COMBINED HYPERLIPIDEMIA [J].
GAGNE, E ;
GENEST, J ;
ZHANG, H ;
CLARKE, LA ;
HAYDEN, MR .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (08) :1250-1257
[8]   Lipoprotein lipase is a gene for insulin resistance in Mexican Americans [J].
Goodarzi, MO ;
Guo, XQ ;
Taylor, KD ;
Quiñones, MJ ;
Saad, MF ;
Yang, HY ;
Hsueh, WA ;
Rotter, JI .
DIABETES, 2004, 53 (01) :214-220
[9]   Determination and use of haplotypes:: Ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans [J].
Goodarzi, MO ;
Guo, XQ ;
Taylor, KD ;
Quiñones, MJ ;
Samayoa, C ;
Yang, HY ;
Saad, MF ;
Palotie, A ;
Krauss, RM ;
Hsueh, WA ;
Rotter, JI .
GENETICS IN MEDICINE, 2003, 5 (04) :322-327
[10]   Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients - The Ser(447)-Stop substitution in the lipoprotein lipase gene [J].
Groenemeijer, BE ;
Hallman, MD ;
Reymer, PWA ;
Gagne, E ;
Kuivenhoven, JA ;
Bruin, T ;
Jansen, H ;
Lie, KI ;
Bruschke, AVG ;
Boerwinkle, E ;
Hayden, MR ;
Kastelein, JJP .
CIRCULATION, 1997, 95 (12) :2628-2635